Genedrive (LON:GDR) had its price objective lifted by Peel Hunt from GBX 150 ($2.07) to GBX 152 ($2.10) in a research report sent to investors on Tuesday morning. Peel Hunt currently has a buy rating on the stock.
Shares of Genedrive (LON:GDR) opened at GBX 34.15 ($0.47) on Tuesday. Genedrive has a 52-week low of GBX 25 ($0.35) and a 52-week high of GBX 45.49 ($0.63). The stock has a market cap of $5.68 and a PE ratio of -97.57.
Genedrive Plc, formerly Epistem Holdings Plc, is a holding company engaged in molecular diagnostics business. The Company operates through segments, including Preclinical Research Services, Pharmacogenomics Services and Diagnostics. Its geographical segments include the United Kingdom, Europe, the United States of America and Asia.
Receive News & Ratings for Genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genedrive and related companies with MarketBeat.com's FREE daily email newsletter.